BeiGene, Ltd.

Ownership Transactions Reported by 22 Insiders

Symbol
BGNE on Nasdaq, BEIGF on OTC
Industry
Pharmaceutical Preparations
Location
C/O Mourant Governance Services (Cayman), 94 Solaris Avenue, Camana Bay, Grand Cayman, Cayman Islands

Insiders trading volume in the past year

BeiGene, Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Hhlr Advisors, Ltd. 10%+ Owner $29.7 B Jun 13, 2023
Amgen Inc 10%+ Owner $3.42 B Sep 10, 2021
Baker Bros. Advisors Lp Director, 10%+ Owner $1.46 B -$199 M -12% Jun 5, 2024
Xiaodong Wang Director, Chair, Scientific Advisory Brd $1.16 B Jun 5, 2024
Donald W. Glazer Director $565 M Jun 5, 2024
John Oyler Chief Executive Officer, Director $387 M -$16.5 M -4.09% Jun 24, 2024
Lai Wang Global Head of R&D $370 M -$538 K -0.15% Jun 24, 2024
Howard Liang CFO & Chief Strategy Officer $323 M Jun 28, 2021
Xiaobin Wu President, COO & GM China $251 M -$738 K -0.29% Jun 24, 2024
Julia Aijun Wang Chief Financial Officer $88.6 M -$420 K -0.47% Jul 1, 2024
Chan Henry Lee SVP, General Counsel $54.8 M -$241 K -0.44% Jun 17, 2024
Jane Huang CMO, Hematology $33.2 M Dec 14, 2021
Thomas Malley Director $15.1 M Jun 15, 2023
Anthony C. Hooper Director $11.2 M Jun 5, 2024
Titus B. Ball Principal Accounting Officer $9.95 M Jun 5, 2024
(Corsee) Sanders Corazon Director $9.61 M Jun 5, 2024
Margaret Dugan Director $9.55 M Jun 5, 2024
Qingqing Yi Director $9.55 M Jun 5, 2024
Alessandro Riva Director $9.55 M Jun 5, 2024
Olivier Brandicourt Director $3.39 M Jun 5, 2024
Timothy Yung-Cheng Chen Director $1.62 M Jun 16, 2021
Jingshyh S. su Director $1.62 M Jun 16, 2021

Recent Insider Transactions by Companies or Individuals for BeiGene, Ltd.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership